VEEV
Veeva Systems Inc.
NYSE · Healthcare · Medical - Healthcare Information Services · US
$275.09
−3.27%Year over year
Reported trailing growth
- Revenue
- +16.5%
- EBITDA
- +41.1%
- EBIT
- +29.5%
- EPS
- +24.7%
- Free cash flow
- +23.7%
- Operating cash flow
- +23.4%
Forward estimates
Based on analyst estimates
- Revenue
- +12.8%
- EBITDA
- +41.2%
- EPS
- +55.3%
Three-year CAGR
- Revenue
- +14.0%
- EBITDA
- +32.3%
- EBIT
- +25.9%
- Net income
- +23.1%
- EPS
- +20.9%
- Free cash flow
- +21.8%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jul 1, 2026